Accelerated Approval Now Full for Pembro in Bladder Cancer Accelerated Approval Now Full for Pembro in Bladder Cancer

A controversial accelerated approval of this immunotherapy, based on response data, has now been converted to a full approval by the FDA.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news